To ask the Secretary of State for Health pursuant to the answer of 4 June 2007, Official Report, columns 279-80W, on blood: imports, (1) how much was spent on commercially imported AHG concentrate/factor VIII blood products by health authorities under arrangements centrally negotiated by her Department in each year from...

To ask the Secretary of State for Health pursuant to the answer of 4 June 2007, Official Report, columns 279-80W, on blood: imports, (1) how much was spent on commercially imported AHG concentrate/factor VIII blood products by health authorities under arrangements centrally negotiated by her Department in each year from...

(2) what records her Department holds on centrally negotiated arrangements for the purchase of commercially imported AHG concentrate/factor VIII blood products for health authorities in the 1970s and 1980s; and if she will make a statement;

(2) what records her Department holds on centrally negotiated arrangements for the purchase of commercially imported AHG concentrate/factor VIII blood products for health authorities in the 1970s and 1980s; and if she will make a statement;

(3) how many blood donations were used to prepare AHG concentrate/factor VIII blood products in the UK in each year from 1977 to 1985; and if she will make a statement.

(3) how many blood donations were used to prepare AHG concentrate/factor VIII blood products in the UK in each year from 1977 to 1985; and if she will make a statement.

(7) how much and what proportion of blood products given to haemophiliacs in (a) 1977, (b) 1978 and (c) 1979 were sourced from UK donors; and if she will make a statement.

(7) how much and what proportion of blood products given to haemophiliacs in (a) 1977, (b) 1978 and (c) 1979 were sourced from UK donors; and if she will make a statement.

(6) what volume of UK-sourced blood was fractionated to develop blood products for use by haemophiliacs in (a) 1977, (b) 1978, (c) 1979, (d) 1985, (e) 1986, (f) 1987, (g) 1988 and (h) 1989; and if she will make a statement;

(6) what volume of UK-sourced blood was fractionated to develop blood products for use by haemophiliacs in (a) 1977, (b) 1978, (c) 1979, (d) 1985, (e) 1986, (f) 1987, (g) 1988 and (h) 1989; and if she will make a statement;

(5) what volume of cryoprecipitate was available for use under the NHS in (a) 1977, (b) 1978, (c) 1979, (d) 1985, (e) 1986, (f) 1987, (g) 1988 and (h) 1989; and if she will make a statement;

(5) what volume of cryoprecipitate was available for use under the NHS in (a) 1977, (b) 1978, (c) 1979, (d) 1985, (e) 1986, (f) 1987, (g) 1988 and (h) 1989; and if she will make a statement;

(4) what volume of factor VIII blood products was imported from the United States into the UK in (a) 1980, (b) 1981, (c) 1982, (d) 1983 and (e) 1984; and if she will make a statement;

(4) what volume of factor VIII blood products was imported from the United States into the UK in (a) 1980, (b) 1981, (c) 1982, (d) 1983 and (e) 1984; and if she will make a statement;

(3) how much and what proportion of blood products given to haemophiliacs in (a) 1980, (b) 1981, (c) 1982, (d) 1983 and (e) 1984 were sourced from US donors; and if she will make a statement;

(3) how much and what proportion of blood products given to haemophiliacs in (a) 1980, (b) 1981, (c) 1982, (d) 1983 and (e) 1984 were sourced from US donors; and if she will make a statement;

(2) how much and what proportion of blood products given to haemophiliacs in (a) 1985, (b) 1986, (c) 1987, (d) 1988 and (e) 1989 were sourced from UK donors; and if she will make a statement;

(2) how much and what proportion of blood products given to haemophiliacs in (a) 1985, (b) 1986, (c) 1987, (d) 1988 and (e) 1989 were sourced from UK donors; and if she will make a statement;

To ask the Secretary of State for Health (1) how much her Department spent on imported blood products from the United States in (a) 1980, (b) 1981, (c) 1982, (d) 1983 and (e) 1984; and if she will make a statement;

To ask the Secretary of State for Health (1) how much her Department spent on imported blood products from the United States in (a) 1980, (b) 1981, (c) 1982, (d) 1983 and (e) 1984; and if she will make a statement;

To ask the Secretary of State for Health what advice her Department received from the World Health Organisation on the safety of imported blood from the United States between 1977 and 1979; and if she will make a statement.

To ask the Secretary of State for Health what advice her Department received from the World Health Organisation on the safety of imported blood from the United States between 1977 and 1979; and if she will make a statement.

(2) what advice her Department received between 1977 and 1989 from the World Health Organisation on the safety of imported blood from the US; and if she will make a statement.

(2) what advice her Department received between 1977 and 1989 from the World Health Organisation on the safety of imported blood from the US; and if she will make a statement.

To ask the Secretary of State for Health (1) what representations her Department received prior to 1990 from the World Health Organisation on the safety of imported blood from areas with a high prevalence of hepatitis; and if she will make a statement;

To ask the Secretary of State for Health (1) what representations her Department received prior to 1990 from the World Health Organisation on the safety of imported blood from areas with a high prevalence of hepatitis; and if she will make a statement;

(3) how much her Department spent on the Lister Institute's (a) Chelsea and (b) Elstree laboratories in each year since 1977; and if she will make a statement.

(3) how much her Department spent on the Lister Institute's (a) Chelsea and (b) Elstree laboratories in each year since 1977; and if she will make a statement.

(9) what volume and proportion of blood products given to haemophiliacs in (a) 1977, (b) 1978 and (c) 1979 were sourced from USA donors; and if she will make a statement.

(9) what volume and proportion of blood products given to haemophiliacs in (a) 1977, (b) 1978 and (c) 1979 were sourced from USA donors; and if she will make a statement.

(8) what volume of factor VIII blood product was imported from the US into the UK in (a) 1985, (b) 1986, (c) 1987, (d) 1988 and (e) 1989; and if she will make a statement;

(8) what volume of factor VIII blood product was imported from the US into the UK in (a) 1985, (b) 1986, (c) 1987, (d) 1988 and (e) 1989; and if she will make a statement;

(2) what volume of factor VIII blood product was imported from the US into the UK in (a) 1977, (b) 1978 and (c) 1979; and if she will make a statement;

(2) what volume of factor VIII blood product was imported from the US into the UK in (a) 1977, (b) 1978 and (c) 1979; and if she will make a statement;

To ask the Secretary of State for Health (1) how much her Department spent on imported blood products from the US in (a) 1977, (b) 1978 and (c) 1979; and if she will make a statement;

To ask the Secretary of State for Health (1) how much her Department spent on imported blood products from the US in (a) 1977, (b) 1978 and (c) 1979; and if she will make a statement;

(5) how much and what proportion of blood products given to haemophiliacs in (a) 1985, (b) 1986, (c) 1987, (d) 1988 and (e) 1989 was sourced from the US; and if she will make a statement;

(5) how much and what proportion of blood products given to haemophiliacs in (a) 1985, (b) 1986, (c) 1987, (d) 1988 and (e) 1989 was sourced from the US; and if she will make a statement;

(3) what volume of UK-sourced blood was fractionated to develop blood products for use by haemophiliacs in (a) 1980, (b) 1981, (c) 1982, (d) 1983 and (e) 1984; and if she will make a statement;

(3) what volume of UK-sourced blood was fractionated to develop blood products for use by haemophiliacs in (a) 1980, (b) 1981, (c) 1982, (d) 1983 and (e) 1984; and if she will make a statement;